Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | XDH | P47989 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | CXCR5 | P32302 | 1/20 | 0.40 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.39 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30675637 | 0.82 | MAPT (0.45) | ALDH1A1MAPK1KDM4EHPGDHSD17B10 | |
| SCHEMBL5195730 | 0.82 | MAPT (0.45) | ALDH1A1MAPK1KDM4EHPGDHSD17B10 | |
| SCHEMBL15388924 | 0.81 | TSHR (0.41) | ALDH1A1XDHLMNAMAPK1HPGD | |
| SCHEMBL4487895 | 0.80 | MAPK1 (0.46) | ALDH1A1XDHLMNAMAPK1KDM4E | |
| Hydrochloric Acid SCHEMBL28326198 | 0.79 | IRAK4 (0.36) | ALDH1A1LMNACXCR5IRAK4 | |
| SCHEMBL4426493 | 0.79 | IRAK4 (0.57) | ALDH1A1MAPK1KDM4EHPGDHSD17B10 | |
| SCHEMBL4037726 | 0.79 | RXRA (0.45) | ALDH1A1XDHMAPK1KDM4EHPGD | |
| Water SCHEMBL21855692 | 0.78 | ALDH1A1 (0.46) | ALDH1A1MAPK1KDM4EHPGDHSD17B10 | |
| SCHEMBL383489 | 0.77 | ALDH1A1 (0.62) | ALDH1A1LMNAMAPK1KDM4EHPGD | |
| SCHEMBL1818841 | 0.77 | IRAK4 (0.54) | ALDH1A1LMNAMAPK1KDM4EHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7605171-B2 | (3,4-disubstituted)propanoic carboxylates as S1P (Edg) receptor agonists | MERCK & CO., INC. (US) | 2009-10-20 | — | — | US | disclosed |
| US-20080249093-A1 | (3,4-Disubstituted)Propanoic Carboxylates as Sip (Edg) Receptor Agonists | MERCK & CO., INC. (US) | 2008-10-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080249093-A1 | (3,4-Disubstituted)Propanoic Carboxylates as Sip (Edg) Receptor Agonists | S1PR1, S1PR3, S1PR5 | ALDH1A1 740/4885XDH 4099/4885LMNA 3260/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.